---
title: Patient Enrollment Begins for Australian Trial
description: Patient Enrollment Begins for Australian Trial
---

[News ](https://www.yourway.com/news)

# [Patient Enrollment Begins for Australian Trial](https://www.yourway.com/news/patient-enrollment-begins-for-australian-trial)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | May 11, 2020

Mesoblast, a Melbourne-based biotech company, began enrolling up to 300 patients for a randomized, controlled study of its [stem cell therapy](https://www.forbes.com/sites/alexknapp/2020/05/02/large-scale-clinical-trials-of-mesoblasts-stem-cell-treatment-for-covid-19-coronavirus-set-to-begin-soon/#33346e644086) remestemcel-L for the treatment of COVID-19. Over 20 hospitals will participate in the study, which is anticipated to last 3-4 months. Yourway is equipped to handle and transport sensitive clinical trial materials, including cell and gene therapies.

[View full post](https://www.yourway.com/news/patient-enrollment-begins-for-australian-trial)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-05-11T09:00:00.412Z",
  "datePublished" : "2020-05-11T09:00:00Z",
  "headline" : "Patient Enrollment Begins for Australian Trial",
  "image" : {
    "@type" : "ImageObject",
    "height" : 810,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/images/news_may/iStock-1135352068.jpg",
    "width" : 1440
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/patient-enrollment-begins-for-australian-trial",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```